These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19797440)

  • 1. Rapid improvement in affective information processing after acute administration of reboxetine.
    Thase ME
    Am J Psychiatry; 2009 Oct; 166(10):1096-9. PubMed ID: 19797440
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel antidepressant strategies to optimize outcome.
    J Clin Psychiatry; 2000 Sep; 61(9):686-96. PubMed ID: 11030494
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.
    Montgomery SA; Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?
    Healy D; Healy H
    J Affect Disord; 1998 Dec; 51(3):313-22. PubMed ID: 10333985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul; 146(27-28):56. PubMed ID: 15526675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reboxetine (Edronax)].
    Souery D; Sternon J
    Rev Med Brux; 1999 Dec; 20(6):511-6. PubMed ID: 10672775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute antidepressant administration on negative affective bias in depressed patients.
    Harmer CJ; O'Sullivan U; Favaron E; Massey-Chase R; Ayres R; Reinecke A; Goodwin GM; Cowen PJ
    Am J Psychiatry; 2009 Oct; 166(10):1178-84. PubMed ID: 19755572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for new and better antidepressants: reboxetine a new option.
    Dencker SJ
    Acta Psychiatr Scand Suppl; 2000; 402():6-11. PubMed ID: 10901153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reboxetine treatment of depression in Parkinson's disease.
    Lemke MR
    J Clin Psychiatry; 2000 Nov; 61(11):872. PubMed ID: 11105742
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract]   [Full Text] [Related]  

  • 11. Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression.
    Scates AC; Doraiswamy PM
    Ann Pharmacother; 2000 Nov; 34(11):1302-12. PubMed ID: 11098346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress.
    First M; Gil-Ad I; Taler M; Tarasenko I; Novak N; Weizman A
    J Mol Neurosci; 2013 May; 50(1):88-97. PubMed ID: 22968760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reboxetine: the first selective noradrenaline re-uptake inhibitor.
    Kasper S; el Giamal N; Hilger E
    Expert Opin Pharmacother; 2000 May; 1(4):771-82. PubMed ID: 11249515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenaline in basic models of depression.
    Leonard BE
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S11-6; discussion S71-3. PubMed ID: 9169306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depersonalization-derealization syndrome induced by reboxetine.
    Khazaal Y; Zullino DF
    Swiss Med Wkly; 2003 Jul; 133(27-28):398-9. PubMed ID: 12947529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.
    Harmer CJ; Hill SA; Taylor MJ; Cowen PJ; Goodwin GM
    Am J Psychiatry; 2003 May; 160(5):990-2. PubMed ID: 12727705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia.
    Ferini-Strambi L; Manconi M; Castronovo V; Riva L; Bianchi A
    J Psychopharmacol; 2004 Sep; 18(3):417-22. PubMed ID: 15358987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants and emotional processing.
    Nathan PJ; Kemp AH; Harrison BJ
    Neuropsychopharmacology; 2003 Jul; 28(7):1383; author reply 1384-5. PubMed ID: 12784110
    [No Abstract]   [Full Text] [Related]  

  • 19. Reboxetine: a preliminary report on its use through the Special Access Program.
    Kennedy SH; Lam RW; Cohen NL; Rosenbluth M; Sokolov ST; McIntyre RS; Chue P; Craigen G;
    J Psychiatry Neurosci; 2002 Nov; 27(6):418-22. PubMed ID: 12491574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov; 36(11):86-8. PubMed ID: 10562766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.